ARTICLE | Company News
Amid restructuring, AstraZeneca adds former MSKCC exec Baselga
January 7, 2019 8:59 PM UTC
AstraZeneca plc (LSE:AZN; NYSE:AZN) will split its R&D operations into two units, and has tapped José Baselga to lead the cancer-focused division.
Baselga resigned as CMO and physician-in-chief of Memorial Sloan Kettering Cancer Center in September after being accused of failing to disclose conflicts of interest. Baselga also stepped down from the board at Bristol-Myers Squibb Co. (NYSE:BMY) (see "COI Failure Fallout"). ...
BCIQ Company Profiles